Journal article
Neuraminidase inhibitors for preventing and treating influenza in children (published trials only)
- Abstract:
-
Background: During epidemics, influenza attack rates in children may exceed 40%. Options for prevention and treatment currently include the neuraminidase inhibitors zanamivir and oseltamivir. Laninamivir octanoate, the prodrug of laninamivir, is currently being developed.
Expand abstract
Objectives: To assess the efficacy, safety and tolerability of neuraminidase inhibitors in the treatment and prevention of influenza in children.
Search methods:
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 814.7KB)
-
- Publisher copy:
- 10.1002/14651858.cd002744.pub4
Authors
Funding
Bibliographic Details
- Publisher:
- Wiley Publisher's website
- Journal:
- Cochrane Database of Systematic Reviews Journal website
- Volume:
- 7
- Issue:
- 4
- Pages:
- CD002744
- Publication date:
- 2012-04-18
- DOI:
- EISSN:
-
1469-493X
- Pmid:
-
22513907
- Source identifiers:
-
325206
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:325206
- UUID:
-
uuid:59c83c7d-3dfe-41e0-9f56-76567a2df022
- Local pid:
- pubs:325206
- Deposit date:
- 2018-03-14
Terms of use
- Copyright holder:
- Cochrane Collaboration
- Copyright date:
- 2012
- Notes:
- © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
If you are the owner of this record, you can report an update to it here: Report update to this record